HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy Jerusalem Selected Research

benthiocarb (Bolero)

5/2014Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.
1/2014Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy Jerusalem Research Topics

Disease

81Breast Neoplasms (Breast Cancer)
08/2022 - 09/2002
53Neoplasms (Cancer)
05/2022 - 09/2002
8Neoplasm Metastasis (Metastasis)
01/2021 - 03/2011
7Triple Negative Breast Neoplasms
08/2021 - 12/2014
6Fatigue
04/2022 - 05/2014
5Cardiotoxicity
09/2021 - 05/2015
5Lymphoma (Lymphomas)
09/2005 - 09/2002
4Neutropenia
01/2021 - 05/2014
4Disease Progression
02/2015 - 11/2013
3Melanoma (Melanoma, Malignant)
08/2021 - 08/2013
3Inflammation (Inflammations)
01/2021 - 04/2003
3Diarrhea
01/2021 - 01/2019
3Febrile Neutropenia
04/2020 - 05/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 01/2020
2Pain (Aches)
01/2022 - 12/2020
2Stomatitis
01/2021 - 05/2014
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2020
2Carcinoma (Carcinomatosis)
01/2020 - 07/2015
1Eosinophilia
05/2022
1Noninfiltrating Intraductal Carcinoma (DCIS)
06/2021
1Asthenia
01/2021
1Malnutrition (Nutritional Deficiencies)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Infections
01/2021

Drug/Important Bio-Agent (IBA)

30Hormones (Hormone)IBA
08/2022 - 02/2012
14Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2015
13EverolimusFDA Link
01/2021 - 01/2011
12Fulvestrant (Faslodex)FDA Link
01/2022 - 10/2010
10Estrogen ReceptorsIBA
10/2018 - 10/2010
9ErbB Receptors (EGF Receptor)IBA
08/2022 - 01/2016
9Trastuzumab (Herceptin)FDA Link
01/2021 - 03/2007
8Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2003
8Aromatase InhibitorsIBA
10/2018 - 02/2012
7ribociclibIBA
01/2022 - 01/2018
7Epidermal Growth Factor (EGF)IBA
09/2019 - 11/2013
6exemestane (Aromasin)FDA Link
01/2021 - 01/2014
5Letrozole (Femara)FDA LinkGeneric
01/2021 - 02/2012
4Matrix Metalloproteinase 17IBA
02/2022 - 12/2014
4AnthracyclinesIBA
09/2021 - 01/2015
4MicroRNAs (MicroRNA)IBA
01/2021 - 02/2015
4Pharmaceutical PreparationsIBA
01/2019 - 08/2013
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2006 - 04/2003
3abemaciclibIBA
08/2022 - 01/2021
3Biological ProductsIBA
05/2022 - 08/2013
3palbociclibIBA
01/2022 - 01/2019
3human ERBB2 proteinIBA
01/2021 - 01/2014
3pertuzumabIBA
01/2021 - 01/2019
3olaparibIBA
11/2018 - 10/2015
3EnzymesIBA
01/2018 - 07/2015
3Messenger RNA (mRNA)IBA
01/2018 - 03/2015
2TamoxifenFDA LinkGeneric
08/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
05/2022 - 01/2021
2Metalloproteases (Metalloproteinases)IBA
02/2022 - 12/2014
2Coloring Agents (Dyes)IBA
02/2022 - 09/2021
2Cyclin-Dependent Kinase 4IBA
01/2021 - 01/2021
2Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2020 - 01/2019
2Methotrexate (Mexate)FDA LinkGeneric
08/2020 - 08/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2020 - 03/2019
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
04/2020 - 03/2019
2avelumabIBA
01/2020 - 01/2018
2LigandsIBA
10/2019 - 01/2018
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 06/2015
2Retinoblastoma ProteinIBA
01/2019 - 12/2014
2trebananibIBA
01/2019 - 06/2015
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 03/2017
2Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2018 - 10/2015
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2017 - 03/2007
2Progesterone Receptors (Progesterone Receptor)IBA
01/2016 - 11/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015 - 08/2013
2taxaneIBA
01/2015 - 05/2014
2benthiocarb (Bolero)IBA
05/2014 - 01/2014
2Vinorelbine (Navelbine)FDA LinkGeneric
05/2014 - 01/2011
2MTOR InhibitorsIBA
01/2014 - 11/2013
2TOR Serine-Threonine KinasesIBA
01/2014 - 11/2013
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2022
1Thymidine KinaseIBA
01/2022
1Taxoids (Taxanes)IBA
09/2021
1liposomal doxorubicin (Doxil)FDA Link
09/2021
1AntidiarrhealsIBA
01/2021
1AntibodiesIBA
01/2021
1xentuzumabIBA
01/2021
1Loperamide (Imodium)FDA LinkGeneric
01/2021
1Hemoglobins (Hemoglobin)IBA
11/2020

Therapy/Procedure

42Therapeutics
08/2022 - 09/2002
28Drug Therapy (Chemotherapy)
09/2021 - 09/2002
8Hypnosis (Mesmerism)
04/2022 - 04/2017
4Neoadjuvant Therapy
08/2021 - 02/2015
4Aftercare (After-Treatment)
11/2020 - 09/2002
4Radiotherapy
01/2019 - 01/2016
2Radical Mastectomy
09/2021 - 06/2021
2Immunotherapy
08/2021 - 01/2021
2Chemoradiotherapy
01/2021 - 11/2020
1Meditation
01/2022
1Resistance Training
01/2022
1Lymph Node Excision (Lymph Node Dissection)
09/2021
1Modified Radical Mastectomy (Mastectomy, Modified)
06/2021
1Conservative Treatment
06/2021
1Activities of Daily Living (ADL)
01/2021
1Drug Tapering
01/2021
1Brachytherapy
01/2021